# NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI

> **NCT02688062** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Sciences** · enrollment: 22 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **BIOLOGICAL:** NeuroRegen Scaffold with BMMCs transplantation
- **PROCEDURE:** Surgical intradural decompression and adhesiolysis

## Key facts

- **NCT ID:** NCT02688062
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2020-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688062, "NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02688062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*